- Home
- CNTB vs ETON Comparison
CNTB vs ETON Comparison
Compare CNTB & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTB
- ETON
- Stock Information
- Founded
- CNTB 2012
- ETON 2017
- Country
- CNTB United States
- ETON United States
- Employees
- CNTB N/A
- ETON N/A
- Industry
- CNTB Biotechnology: Pharmaceutical Preparations
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- CNTB Health Care
- ETON Health Care
- Exchange
- CNTB Nasdaq
- ETON Nasdaq
- Market Cap
- CNTB 68.5M
- ETON 199.5M
- IPO Year
- CNTB 2021
- ETON 2018
- Fundamental
- Price
- CNTB $1.17
- ETON $8.82
- Analyst Decision
- CNTB Strong Buy
- ETON Strong Buy
- Analyst Count
- CNTB 1
- ETON 3
- Target Price
- CNTB $8.00
- ETON $12.00
- AVG Volume (30 Days)
- CNTB 24.6K
- ETON 214.1K
- Earning Date
- CNTB 09-05-2024
- ETON 11-11-2024
- Dividend Yield
- CNTB N/A
- ETON N/A
- EPS Growth
- CNTB N/A
- ETON N/A
- EPS
- CNTB N/A
- ETON N/A
- Revenue
- CNTB $24,116,000.00
- ETON $31,381,000.00
- Revenue This Year
- CNTB N/A
- ETON $19.61
- Revenue Next Year
- CNTB $63.90
- ETON $35.39
- P/E Ratio
- CNTB N/A
- ETON N/A
- Revenue Growth
- CNTB N/A
- ETON 8.14
- 52 Week Low
- CNTB $0.68
- ETON $3.03
- 52 Week High
- CNTB $2.84
- ETON $8.66
- Technical
- Relative Strength Index (RSI)
- CNTB 44.02
- ETON 76.07
- Support Level
- CNTB $1.18
- ETON $7.58
- Resistance Level
- CNTB $1.26
- ETON $8.66
- Average True Range (ATR)
- CNTB 0.07
- ETON 0.42
- MACD
- CNTB -0.01
- ETON -0.07
- Stochastic Oscillator
- CNTB 13.59
- ETON 91.49
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.